United States· US:46708-812_c0b487dd-a47b-42fd-a855-5d237c5651a9
Triamcinolone Acetonide
A medicinal product containing triamcinolone acetonide, registered in United States by Alembic Pharmaceuticals Limited.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TRIAMCINOLONE ACETONIDE
- Manufacturer
- Alembic Pharmaceuticals Limited
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1146708812011 VIAL, SINGLE-DOSE in 1 CARTON (46708-812-01) / 1 mL in 1 VIAL, SINGLE-DOSE
- ndc11467088122525 VIAL, SINGLE-DOSE in 1 CARTON (46708-812-25) / 1 mL in 1 VIAL, SINGLE-DOSE
- ndc1146708-812-01
- ndc1146708-812-25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Triamcinolone acetonide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyKortikoidRatiopharm Gmbh
- United KingdomAdcortyl in Orabase 0.1% oromucosal pasteBristol-Myers Squibb Pharmaceuticals Ltd
- NetherlandsCremor triamcinolonacetonide 0,1% Mylan, creme 1 mg/gMylan B.V.
- NorwayKenacort RetardBristol-Myers Squibb
- BelgiumAlbicort 10Sanofi Belgium
- CanadaAPO-TRIAMCINOLONE AQAPOTEX INC
- FinlandAftabMeda Oy
- Japanトリアムシノロンアセトニドアルフレッサファーマ
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Volon, Volon A
- Belgium · Delphi, Kenacort-A
- Cyprus · Triacort
- Czechia · Triamcinolon Léčiva
- Germany · Nasacort, Rhinisan
- Denmark · Kenalog, Triamcinolone Acetonide Medipha
- Estonia · Kenalog
- Spain · Nasacort
- Finland · Nasacort, Triamcinolone Medipha
- France · Kenacort Retard, Nasacort
- United Kingdom (Northern Ireland) · Nasacort
- Greece · Jiven, Nasacort
- Croatia · Kenalog
- Hungary · Ftorocort, Kenalog
- Ireland · Nasacort, Nasacort Allergy
- Iceland · Kenacort-T, Nasacort
- Italy · Kenacort, Nasacort
- Lithuania · Ftorocort, Kenalog
- Luxembourg · Delphi, Kenacort-A
- Latvia · Ftorocort, Kenalog
- Malta · Nasacort, Nasacort Allergy
- Netherlands · Cremor Triamcinolonacetonide, Kenacort-A 10
- Norway · Kenacort-T, Nasacort
- Poland · Polcortolon
- Portugal · Nasacort, Telfast Spray Nasal
- Sweden · Kenacort-T, Nasacort
- Slovenia · Kenalog
- Slovakia · Triamcinolon Crm Léčiva, Triamcinolon Ung Léčiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/adee889a-8751-438c-b528-bf7ee2572d5d GET /v1/drugs/adee889a-8751-438c-b528-bf7ee2572d5d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRA-ARTICULAR; INTRAMUSCULAR",
"source": "ndc",
"strength": "40",
"substance": "TRIAMCINOLONE ACETONIDE",
"productndc": "46708-812",
"dosage_form": "INJECTION, SUSPENSION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA218601",
"marketing_category": "ANDA"
}See everything about triamcinolone acetonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.